BPRG Bioprogress

RNS Number:3595C
BioProgress PLC
17 August 2007


For Immediate Release                                             17 August 2007



                BioProgress plc ('BioProgress' or the 'Company')



                                 Trading update



London UK, 17th August 2007, the Board of BioProgress (AIM: BPRG), the specialty
pharmaceutical and healthcare company  has noted the recent fall in its share
price and whilst recognising the volatility in the UK stock market generally,
provides the following update.



Following the announcement on 28 June 2007 of the acquisition of Melbrosin,
BioProgress is pleased to announce that the integration of the new business is
progressing well.  The core products are performing to plan and cross
fertilisation of products into the other business units has commenced.



New product development and partner programmes remain on course to deliver to
the Company's expectations.



The Board is confident that the strategy put into place is being executed to
plan.  The Company remains on track to achieve market expectations for 2007.





For further information:


BioProgress Plc                                            + 44 (0) 20 7098 9881
Richard Trevillion, CEO

Steve Martin, CDO

Hiral Patel, CFO
Buchanan Communications                                    + 44 (0) 20 7466 5000
Rebecca Skye Dietrich

Mark Court





About BioProgress

BioProgress plc is an innovative specialty pharmaceutical and healthcare
business based around its platform technologies in polymer and film systems.
Listed on London's AIM in May 2003, the company has over 80 patents granted or
in application within 24 patent families and has product development agreements
and strategic alliances with several global companies. As a virtually integrated
business, BioProgress has acquired sales and marketing resources within Europe
and the US as a launch mechanism for its own pharmaceutical and healthcare
products. The business continues to develop innovative delivery mechanisms using
its XGELTM polymer technology. For further information please go to
www.bioprogress.com






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

SPMPRMTTMMABBLR

Bioprogress (LSE:BPRG)
Historical Stock Chart
From Apr 2024 to May 2024

Bioprogress (LSE:BPRG)
Historical Stock Chart
From May 2023 to May 2024